全文获取类型
收费全文 | 447811篇 |
免费 | 24519篇 |
国内免费 | 15491篇 |
专业分类
耳鼻咽喉 | 3712篇 |
儿科学 | 10264篇 |
妇产科学 | 8573篇 |
基础医学 | 48942篇 |
口腔科学 | 6402篇 |
临床医学 | 46882篇 |
内科学 | 75948篇 |
皮肤病学 | 4238篇 |
神经病学 | 32078篇 |
特种医学 | 18400篇 |
外国民族医学 | 108篇 |
外科学 | 59345篇 |
综合类 | 39681篇 |
现状与发展 | 52篇 |
一般理论 | 71篇 |
预防医学 | 35286篇 |
眼科学 | 10531篇 |
药学 | 35878篇 |
180篇 | |
中国医学 | 12365篇 |
肿瘤学 | 38885篇 |
出版年
2024年 | 758篇 |
2023年 | 3878篇 |
2022年 | 9498篇 |
2021年 | 12644篇 |
2020年 | 9324篇 |
2019年 | 8497篇 |
2018年 | 30059篇 |
2017年 | 24569篇 |
2016年 | 26442篇 |
2015年 | 12148篇 |
2014年 | 14970篇 |
2013年 | 14201篇 |
2012年 | 26624篇 |
2011年 | 41944篇 |
2010年 | 31370篇 |
2009年 | 21758篇 |
2008年 | 33607篇 |
2007年 | 35932篇 |
2006年 | 14766篇 |
2005年 | 16437篇 |
2004年 | 13339篇 |
2003年 | 13220篇 |
2002年 | 10249篇 |
2001年 | 7150篇 |
2000年 | 7415篇 |
1999年 | 7442篇 |
1998年 | 4340篇 |
1997年 | 4281篇 |
1996年 | 3225篇 |
1995年 | 3027篇 |
1994年 | 2611篇 |
1993年 | 1777篇 |
1992年 | 2755篇 |
1991年 | 2495篇 |
1990年 | 2203篇 |
1989年 | 1890篇 |
1988年 | 1661篇 |
1987年 | 1517篇 |
1986年 | 1292篇 |
1985年 | 1046篇 |
1984年 | 699篇 |
1983年 | 565篇 |
1982年 | 355篇 |
1981年 | 315篇 |
1980年 | 309篇 |
1979年 | 396篇 |
1978年 | 259篇 |
1977年 | 226篇 |
1974年 | 258篇 |
1973年 | 224篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
61.
Effects of Price,Information, and Transactions Cost Interventions to Raise Voluntary Enrollment in a Social Health Insurance Scheme: A Randomized Experiment in the Philippines 下载免费PDF全文
Joseph J. Capuno Aleli D. Kraft Stella Quimbo Carlos R. Tan Jr. Adam Wagstaff 《Health economics》2016,25(6):650-662
A cluster randomized experiment was undertaken testing two sets of interventions encouraging enrollment in the Individually Paying Program (IPP), the voluntary component of the Philippines' social health insurance program. In early 2011, 1037 unenrolled IPP‐eligible families in 179 randomly selected intervention municipalities were given an information kit and offered a 50% premium subsidy valid until the end of 2011; 383 IPP‐eligible families in 64 control municipalities were not. In February 2012, the 787 families in the intervention sites who were still IPP‐eligible but had not enrolled had their vouchers extended, were resent the enrollment kits and received SMS reminders. Half the group also received a ‘handholding’ intervention: in the endline interview, the enumerator offered to help complete the enrollment form, deliver it to the insurer's office in the provincial capital, and mail the membership cards. The main intervention raised the enrollment rate by 3 percentage points (ppts) (p = 0.11), with an 8 ppt larger effect (p < 0.01) among city‐dwellers, consistent with travel time to the insurance office affecting enrollment. The handholding intervention raised enrollment by 29 ppts (p < 0.01), with a smaller effect (p < 0.01) among city‐dwellers, likely because of shorter travel times, and higher education levels facilitating unaided completion of the enrollment form. Copyright © The World Bank Health Economics © 2015 John Wiley & Sons, Ltd. 相似文献
62.
Wen Wang Yanmei Liu Chuan Yu Jing Tan Weiyi Xiong Duo Dong 《Expert opinion on drug safety》2020,19(3):339-347
ABSTRACTObjectives: Limited evidence has suggested that cefoperazone-sulbactam causes coagulation disorders and bleeding.Methods: The authors conducted a retrospective study to compare patients receiving cefoperazone-sulbactam versus those treated with cefoperazone-tazobactam or ceftazidime. Propensity-score matching was used to explore whether treatment with cefoperazone-sulbactam increased the risk of prothrombin time (PT) prolongation, coagulation disorders, and bleeding, or decreased platelets (PLT).Results: The cohort included 23,242 patients. Among patients receiving cefoperazone-sulbactam, the risk of PT prolongation, coagulation disorders, decreased PLT, and bleeding was 5.3%, 9.2%, 15.7%, and 4.2%, respectively. Propensity-score matching analyses suggested that cefoperazone-sulbactam increased the risk of PT prolongation (aOR 2.26, 95% CI 1.61–3.18), coagulation disorders (aOR 1.81, 95% CI 1.43–2.30), and decreased PLT (aOR 1.46, 95% CI 1.25–1.72), but not increase bleeding (aOR 1.05, 95% CI 0.79–1.40) compared with ceftazidime. Patients receiving cefoperazone-sulbactam had higher risk of PT prolongation (aOR 1.53, 95% CI 1.11–2.10), coagulation disorders (aOR 1.53, 95% CI 1.21–1.95), but not decreased PLT (aOR 0.93, 95% CI 0.81–1.07) or bleeding (aOR 1.11, 95% CI 0.87–1.42), compared with those receiving cefoperazone-tazobactam.Conclusion: Cefoperazone-sulbactam may be associated with a higher risk of PT prolongation and coagulation disorders compared with cefoperazone-tazobactam and ceftazidime. 相似文献
63.
近年来,血管外科腔内治疗手段飞速发展和进步,因其创伤小、并发症少、术后恢复快及对患者一般情况要求较宽松等优势,使得很多临床医生和患者更倾向于通过腔内手段治疗血管疾病,逐渐忽视了外科手术治疗的重要性,甚至出现忽视患者病情的个体情况而盲目选择腔内治疗的趋势。作为血管疾病治疗的重要方式,开放手术乃是血管外科的立家之本,是血管外科临床医生的基本技能,在很多情况下有着不可替代的作用,应当再次被强调、被重视。 相似文献
64.
65.
[目的]对静脉输注操作中的排气法进行改进,使其更适合护理工作.[方法]同1名护理人员对相同病人分别用两种排气法进行静脉输注.[结果]改进的静脉输注排气法最大限度地缩短了操作时间,提高了排气一次成功率,同时减少了药物的丢失量.[结论]改进后的静脉输注排气法有很大的实用性和可行性,提高了一次性排气成功率,缩短了操作时间,使整个操作更连贯,方便. 相似文献
66.
Hai-hong Chen Liang Chai Wei Pan 《中国医学科学杂志(英文版)》2006,21(3):197-200
VAGAL paraganglioma VP)is an uncommonneoplasm originating from neural crest paragan-glion cells located along the vagus nerve,repre-senting less than5%of all paragangliomas of the head andneck.1Despite improvement in microsurgical techniques,management of… 相似文献
67.
68.
69.
70.